AB145. SOH24AB_179. Assessing factors associated with sentinel lymph node positivity in breast cancer patients over the age of 70 years: is there still a role for axillary staging in select patients?

Authors

Yareen Agha

Published

May 1, 2024

Abstract

Background: International guidelines are increasingly advocating for sentinel lymph node (SLN) omission in early breast cancer patients over 70 years. Studies examining such omission in patients with more aggressive phenotypes [lobular subtype/grade 3/lymphovascular invasion (LVI)] are lacking. The aim was to assess the rate of nodal positivity in these subgroups.